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New York
Enhanced end-organ responsiveness of the uremic kidney to the
natriuretic factor. In chronic renal disease, the addition of a fixed
quantity of Na to the extracellular fluid (ECF) will evoke a natriu-
retic response per nephron which is inversely proportional to the
glomerular filtration rate (GFR). One factor that could contribdte
to this "magnification" phenomenon is an increased sensitivity of
residual nephrons to physiologic natriuretic forces. The present
studies were designed to examine this possibility. Natriuretic urine
fractions from uremic patients, infused into one renal artery of
normal rats, produced a small but significant unilateral natriuresis.
Infusion of the same fractions in identical amount into remnant
kidneys of stage II nonuremic rats (i.e., rats with a contralateral
normal kidney in situ) produced a natriuresis in the remnant
kidney only which was equivalent to that observed in the normal
kidneys. The iv. infusion of natriuretic fractions into stage 11 rats
produced comparable increments in the fractional excretion of
sodium (FEN) bilaterally. However, when the natriuretic fractions
were infused into remnant kidneys of stage Ill rats (no con-
tralateral kidney), FENa was significantly greater than in the
foregoing groups. Because stage III rats have increased control
values for FEND, baseline FEND was increased to an equivalent level
in normal rats by unilateral renal denervation. Natriuretic factor
was administered into the ipsilateral renal artery. Although the
natriuretic response was increased, it was significantly less than in
the stage III remnant kidneys. The data support the view that the
uremic state per se is associated with an enhanced responsiveness
of the residual nephrons to the natriuretic factor found in the urine
(and blood) of uremic patients.
Réponse accrue du rein urémique au facteur natriurétique. Au
cours de l'insuffisance rénale chronique, l'addition d'une quantite
déterminée de sodium (Na) au liquide extracellulaire (ECF) deter-
mine une reponse natriurétique par néphron qui est inversement
proportionnelle au debit de filtration glomerulaire (GFR). Un
facteur qui pourrait contribuer a cc phénomène de "magnifica-
tion" est l'augmentation de Ia sensibilité des néphrons résiduels
aux forces natriuretiques. Ce travail a pour but d'étudier cette
possibilité. Les fractions natriuretiques de l'urine de sujets uré-
miques, injectées dans une artère rénale de rat normal, déterminent
une natriurèse unilatérale minime mais significative. L'injection de
Ia mCme quantite des mêmes fractions dans Ic rein lésé de rats du
stade II non urémiques (rats avec un rein controlatéral en place)
produit une natriurése dans Ic rein lésé seulement, natriurèse
équivalente a celle observée dans les reins normaux. L'admini-
stration intra-veineuse de fractions natriurétiques a des rats
du stade II produit une augmentation bilatérale comparable de.
FEN. Cependant, quand les fractions natriurétiques sont injectées
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dans es reins lésés des animaux du stade III (pas de rein con-
trolatéral), FENa est significativement plus grand que dans Ic
groupe précédent. Puisque les rats du stade Ill ont des valeurs
contrôles de FEN, augmentées, FEND basal a été amené a on niveau
comparable chez des rats normaux par Ia dénervation rénale unila-
térale. Le facteur natriurétique a été administré dans l'artère rénale
ipsilatérale. Bien que Ia réponse natriurétique ait été plus grande
dIe est restée significativement inférieure a celle obtenue dans les
reins lésés des animaux do stack III. Ces résultats sont en faveur
de l'idée que l'état urémique par lui méme est associé a one aug-
mentation de Ia capacité de réponse des néphrons résiduels au
facteur natriurétique qui existe dans l'urine (ct Ic sang) des malades
urémiques.
The biologic control system regulating sodium ex-
cretion by the kidney undergoes a progressive "mag-
nification" response throughout the course of chronic
renal disease [1—41. This adaptation is characterized
by an increase in fractional sodium excretion (FENa)
which is inversely proportional to the glomerlular
filtration rate (GFR) and which occurs without a
concomitant increase in sodium intake. It is by virtue
of this transformation in nephron function that the
uremic patient continues to maintain external sodium
balance as GFR falls to very low concentrations
without the necessity for progressive salt restriction.
How the magnification response is mediated re-
mains a matter of speculation. One possibility is that,
as GFR falls, the same perturbation of extracellular
fluid (ECF) volume (such as the minimal expansion
produced by the amount of NaCI in a normal diet)
evokes an ever-increasing degree of activation of the
sodium control system, and in some manner affects
the release of an increasing quantity of "natriuretic
forces." The latter would act on the residual neph-
rons inhibiting net sodium reabsorption. A second
possibility is that the sensitivity of the residual neph-
rons to one or more of the "natriuretic forces" in-
creases adaptively as GFR falls. The two mechanisms
are in no way mutually exclusive.
Among the presumed natriuretic forces in chronic
uremia is a circulating inhibitor of sodium transport
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which is found in both the serum and urine of chroni-
cally uremic patients and dogs [5—7]. The same factor
exists in the urine of normal dogs with chronic ECF
volume expansion undergoing mineralocorticoid hor-
mone "escape" [8], and in normal young men under-
going "water immersion" natriuresis [91. There ap-
pears to be a correlation between the activity of a
natriuretic factor and the concurrent requirements
for sodium excretion per nephron in the subjects or
animals from which the test materials have been ob-
tained [6—8], and we believe, on the basis of cumula-
tive evidence, that this natriuretic factor could be
among the physiologic mediators of sodium excre-
tion. The rate of production of this natriuretic factor
appears to be increased in uremia in the absence of an
increased intake of NaCl as evidenced by increased
plasma concentrations at the same time that urinary
excretion rates are increased [5, 6]. Previous studies,
however, have not examined whether an altered re-
sponsiveness of the kidney plays an additional role in
the magnification response of uremia. The present
study represents an effort to evaluate the possibility
that the sensitivity of the kidney to the natriuretic
factor increases in uremia.
Methods
Preparation of urine fractions. Timed urine collec-
tions, either 12 or 24 hr in duration, were obtained
from patients with advanced chronic renal failure of
various etiologies and from normal subjects. Endog-
enous creatinine clearance was less than 15 mI/mm in
all of the patients. All subjects, whether uremic or
normal, were on an average (i.e., unrestricted) salt
intake, and all were judged on clinical grounds to be
in external sodium balance. None of the uremic
patients were being maintained with intermittent
hemodialysis. The technique of processing the urine
samples has been described previously [6]. In brief,
the original 12- or 24-hr urine collection was concen-
trated by lyophilization and 25 ml of the concentrate,
representing the equivalent of a 5-hr urine sample,
was filtered through Sephadex G25. Elution was per-
formed with a solution of 10 mrvt ammonium acetate
at a pH of 6.8. The partition of the effluent solution
and the fraction used for study have been described in
detail previously [6]. Each fraction employed in the
present study was pretested using a standard bioassay
system [5, 6]. According to the criteria previously
established [5, 6], only uremic fractions which were
"natriuretic" and normal fractions which were "non-
natriuretic" were employed in the present studies.
Natriuretic fractions. Twenty-five experiments were
performed using the natriuretic fractions obtained
from nine uremic patients. Each of the nine fractions
was infused into the left renal artery of nine uremic
(i.e., stage III) hydropenic rats with a solitary "rem-
nant" kidney. An identical volume of each of six of
these fractions was infused into the renal artery of six
normal hydropenic (i.e., stage I) rats. Three of these
fractions were also infused into the renal artery of the
remnant kidney of hydropenic nonuremic (i.e. stage
II) rats in which the contralateral kidney had not
been removed. Finally, seven of the nine fractions
were infused into the left renal artery of normal rats
subjected to left renal denervation at least three hours
prior to the infusion, Two of the above fractions plus
additional fractions from three other patients were
infused intravenously into five stage II rats. The ef-
fects on the remnant kidney were compared with
those simultaneously produced in the contralateral
normal organ. These animals received 0.2% NaCI in
lieu of drinking water for two days prior to the ex-
periment as described previously [5, 6].
Nonnatriuretic fractions. Fourteen experiments
were performed using nonnatriuretic fractions from
ten normal subjects. Five of the fractions were in-
fused into the left renal artery of stage I hydropenic
rats. Four of these five fractions were also infused
into the left renal artery of normal rats subjected to
left renal denervation. The other five fractions were
infused into the solitary renal artery of stage III rats.
Surgical procedures and method of bioassay. The
"remnant kidneys" in the stage II and stage III ani-
mals were produced by infarcting approximately 75%
of the left kidney. This was accomplished by ligating
second and third order branches of the renal artery.
In the stage III rats, the right kidney was removed in
a separate surgical procedure. Unilateral renal dener-
vation was performed as described below.
On the day of the experiment, each test animal was
anesthetized lightly with ether and its left renal artery
was exposed through a longitudinal flank incision.
Retroperitoneal fat and connective tissue were care-
fully separated with moist cotton-tipped applicators
and the renal artery was cannulated using a bent 33-
gauge needle with a PE-lO polyethylene extension.
The technique of unilateral renal arterial cannulation
has been described previously [10]. The polyethylene
catheter was sutured to the subcutaneous tissues of
the back and brought to the exterior at the base of the
tail. The test solutions were infused through the in-
traarterial catheter in the manner described below.
Unilateral renal denervation was performed by ex-
posing the left renal artery through a flank incision,
dissecting the surrounding tissue, gently scraping and
severing all visible nerves and then applying lidocaine
topically to the exposed renal pedicle.
In all rats with two kidneys (stage I, stage II, and
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stage I with left renal denervation), urine from the
left kidney was obtained through a PE-50 catheter
with a tapered tip. The latter was introduced into the
ureter via a midline abdominal incision, Urine from
the right kidney was obtained through a bladder
catheter. In the stage III animals, urine was collected
via a bladder catheter. Complete emptying of the
bladder was facilitated in the manner described pre-
viously [5]. The jugular vein and femoral artery were
also cannulated routinely. The rats then were placed
in a standard plastic (Lucite) restraining chamber
and were allowed to recover from the anesthetic. All
studies were carried out after a recovery period of
approximately one hour with the animals fully
awake. A priming dose of 3 Ci '4C-inulin and 5 Ci
of 3H-para-aminohippurate (3H-PAH) in a volume of
1 ml of 0.9% NaCl was administered intravenously
over a five-mm interval. A sustaining infusion con-
taining 1.5 tCi/ml of '4C-inulin and 2.5 tCi/ml
of 3H-PAH in a vehicle of 0.45% NaCl was infused
at a rate of 20 il/min throughout the experi-
ment using a Harvard syringe pump. A one- to two-
hour period of equilibration was allowed after the
initiation of the sustaining infusion for stabilization
of the rate of urine flow. Three 15-mm control clear-
ance periods were then obtained. During the equili-
bration period and the three control periods, 0.9%
NaCI containing 4 mrvi KCI (pH 7.4) was infused into
the renal arterial catheter at a rate of 20 tI/min. At
the completion of the third control period, the in-
traarterial infusate was changed to one containing the
experimental fraction. (The sodium and potassium
concentrations of the latter were adjusted to 150 and
4 mEq/liter, respectively; the pH was titrated to 7.4.)
The rate of infusion was maintained at 20tl/min.
Three additional 15-mm experimental clearance peri-
ods were then obtained. Finally, in a number of ex-
periments, the test solution containing the unknown
fraction was replaced by the original NaCl-KCI solu-
tion, and three follow-up 15-mm clearance periods
were obtained. The quantity of fraction administered
during the three experimental periods was equivalent
to the total amount harvested from a two-hr urine
sample.
In five of the experiments on stage II rats, the same
amount of fraction was administered intravenously
over a five-mm period via the jugular vein cath-
eter. Urine collections were made from both kidneys
as described above.
Blood was drawn at the midpoint of each urine
collection period via the femoral arterial cannula.
Blood pressure was measured using a mercury ma-
nometer just prior to obtaining the blood samples. If
the arterial catheter did not function properly,
venous blood was obtained from the tail.
Samples of plasma (25 gil) and urine (50 tl) were
pipetted into plastic counting vials containing ten ml
of Aquasol (New England Nuclear Co.), and '4C and
3H activity were counted using a liquid scintillation
spectrometer (Packard Tricarb, Model 3214, Packard
Instrument Co., Inc., Downes Grove, IL). At least
10,000 counts were obtained on each samples. So-
dium and potassium concentrations were measured
on both serum and urine samples using a flame pho-
tometer (Model 43, Instrumentation Laboratory,
Inc., Lexington, MA).
Two prospective criteria were established for the
acceptability of an experiment: 1) In the rats in which
one or both kidneys had a normal complement of
nephrons, a GFR of greater than 0.7 mI/mm per
kidney was required. 2) In all groups, constancy of
sodium excretion rates during the three control peri-
ods was required. The latter was defined as a change
in absolute Na excretion (UNaV) of no more than
20% in either direction between the first and third
control period.
Statistical analyses were performed in the follow-
ing manner. When experimental results were com-
pared with control data obtained in individual rats
such that the same kidney served as its own control,
mean values for the respective sets of clearance peri-
ods were compared using a paired t test. When com-
parison was made between the two kidneys of the
same animal, significance also was determined using
a paired t test. When the experimental results be-
tween groups were compared, an unpaired t test was
employed.
Results
Figure 1 depicts the results of two representative
experiments in stage I normal hydropenic rats. In one
of these, a natriuretic fraction was infused into the
left renal artery; in the other, a nonnatriuretic factor
was infused. In both experiments, values for FENa,
UNaV and GFR were obtained for the infused and
contralateral kidneys. The uremic fraction produced
a significant increase in both FENa and UN8V in the
infused kidney, and values for both returned towards
control levels in the follow-up periods. GFR re-
mained stable throughout. The contralaterat kidney
was unaffected. The nonnatriuretic (normal) fraction
produced no changes in FENa, UNaV or GFR in
either kidney.
Uremic fractions. In Table 1, composite data are
shown for the six experiments in which natriuretic
fractions were infused into the left renal artery of
stage I rats. Composite data are also shown in Table
I for the six experiments in which the same fractions
were infused into the renal arteries of six stage III rats
[blood urea nitrogen (BUN) concentration, 64.5 ±
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4.2 mg/l00 ml]. Finally, data are included in Table 1
for the experiments in which three of these uremic
fractions were infused into the renal artery of the
remnant kidneys of stage II rats.
Normal (stage I) rats. In the stage I rats, the values
for both AUNaV and AFENa were statistically signifi-
cant in the infused organs, ( + 0.87 tEq/min and +
0.60%, respectively). GFR did not change. No
changes in values for any of the parameters were
observed in the contralateral noninfused kidneys. No
significant changes were observed in blood pressure,
hematocrit, CPAH, plasma sodium or potassium con-
centrations or potassium excretion.
Uremic (stage III) rats. In the stage III rats, the
values for AUNaV (+ l.90iEq/min) and AFENa (+
1.85%) were not only significant in relation to the
control values in the same animals, but they were
significantly greater than the comparable increments
in sodium excretion observed in the stage I rats re-
ceiving the same fractions. The stage III animals also
failed to show any significant changes in blood pres-
sure, hematocrit, C11, plasma Na and K concentra-
tions, or potassium excretion.
In both the normal stage I rats and the uremic
stage III rats, the natriuresis induced by the fractions
was apparent during the first 15-mm experimental
Table 1. Fractions from uremic patients infused (a) into the left renal artery of stage 1 (normal) rats, (b) into the solitary renal
artery of stage Ill (uremic) rs with a single remnant kidney, and (c) into the remnant kidney of stage II rats (intact kidney plus
remnant kidney): effects on glomerular filtration rate and sodium excretion
Fraction
(a) Stage I rats (left kidney) (b) Stage III rats (remnant kidney) (c) Stage II rats (remnant kidney)
C1
tn//mm
UNV
j.tEq/min
FENa C1 UNaV
% mi/mm iEq/mmn
FENa
%
C1n UNaV
mi/mm .4Eq/min
FENa
%
CO Control
AP Control
JO Control
P0 Control
LU Control
DI Control
Mean control SEM
Means + SEM
Pexp.vs.control
1.37
+0.02
1.42
—0.06
0.97
—0.15
1.30
—0.18
1.41
—0.32
1.65
—0.62
1.35+0.09
—0.18+0.12
NS
0.49
+0.57
1.38
+1.13
0.63
+0.70
1.06
+0.69
0.47
+0.94
0.37
+1.22
0.73+0.16
0.87+0.11
<0.001
0.23 0.68 0.53
+0.23 —0.13 +1.26
0.66 0.35 0.50
+0.52 +0.05 +0.60
0.43 0.51 0.91
+0.68 +0.16 +3.10
0.60 0.69 1.90
+0.53 +0.05 +1.41
0.24 0.75 3.07
+0.64 +0.01 +3.42
0.10 0.44 0.38
+1.0 +0.02 +1.61
0.38±0.09 0.57+0.06 1.21+0.43
+0.60±0.10 +0.04+0.04 + 1.90±0.45
<0.0025 NS <0.01
0.57
+1.84
1.08
+0.94
1.36
+2.72
1.80
+1.23
2.92
+2.48
0.91
+1.90
1.44±0.34
1.85±0.28
<0.005
0.65 0.51
—0.01 +0.13
— —
— —
— —
— —
0.31 0.25
—0.02 +0.26
— —
— —
0.65 0.38
+0.11 +0.27
0.53+0.11 0.38±0.08
+0.03+0.04 +0.22±0.05
NS <0.025
0.51
+0.34
—
—
—
0.91
+0.61
—
—
0.41
+0.43
0.61+0.15
0.46±0.08
<0.025
P stage I vs. stage II <0.05
<0.0005
Uremic fraction Normal fraction
• •_.__. •
-- _-.—-.--.--• S
I I I I I I I I
0 30 60 90 120
Time, rn/n
Fig. 1. Effects of uremic vs. normal urine fraction on FENa, UN V and GFR, in two typical
experiments. The solid line indicates values for the left (infused) kidney. The dotted line
indicates values for the right (noninfused kidney). The experimental period was preceded
and followed by control periods during which 0.9% NaCI containing 4 mEq/liter of KCI
was infused. Infusion rate was 20 l/min throughout.
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period. The values for AUNaV and AFEN8 (com-
paring the results of the first experimental period with
the mean of the three control periods) were statis-
tically significant in both groups of animals. More-
over, the magnitude of the natriuresis during the first
experimental period was significantly greater in the
stage III rats (AUNaV, 1.41 uEq/min; FENa, 1.34%)
than in the stage I rats (AUNaV, 0.62 Eq/min;
L\FENa, 0.46%) (P < 0.025).
Nonuremic (stage II) rats with one normal and one
remnant kidney. For the three stage II rats in which
the natriuretic fractions were infused into the renal
artery of the remnant kidney (Table 1), the BUN
averaged 37.0 4.2 mg/100 ml. The mean control
value for GFR in the remnant kidneys of the stage II
rats (0.53 0.11 mI/mm) was closely comparable to
the control GFR for the remnant kidney of the stage
Ill rats receiving the same fractions (0.6 0.08
mi/mm). Values for both UNaV and FENa increased
in the remnant kidneys, but the increments, though
statistically significant, were small in magnitude
(LUNaV = +0.22 pEq/min, and AFENa = +0.46%).
No changes occurred in sodium excretion in the con-
tralateral, noninfused kidneys. In comparing the re-
sponse of the stage 11 remnant kidneys with the stage
Ill remnant kidneys, in which the same natriuretic
fractions were employed, the increments in both
UNaV and FENa were significantly greater in the latter
group (P <0.001 and P < 0.005, respectively). More-
over, the values for both AUNaV and LFENa in the
remnant kidneys of the stage II rats were not signifi-
cantly different from those observed in the stage I rats
receiving the identical natriuretic fractions.
In order to compare further remnant and normal
kidneys in identical (nonuremic) environments and at
comparable baseline fractional sodium excretion
rates, five uremic fractions were administered by i,v.
infusion into salt-loaded stage II rats. The results of
this maneuver are shown in Table 2. Control values
for GFR and UNaV were greater in the intact than the
remnant kidney (P < 0.001 and P < 0.025, respec-
tively); however, FENa was not significantly different
between the two kidneys. Infusion of the fractions
caused a small decrease in GFR in the intact kidney
and led to a significant increase in UNaV and FENa in
both kidneys. UNaV was significantly greater for
the intact than the remnant kidney, whereas AFENa
was not significantly different between the two.
Rats with left renal denervation. The results of the
infusion of the natriuretic fractions into the renal
arteries of denevervated kidneys of seven stage I rats
are shown in Table 3. In the noninfused normal con-
tralateral kidneys (not shown in the table), the con-
trol value for GFR was 1.12 + 0.04 mI/mm; for
UNaV, 0.52 + 0.20 tEq/min; and for FENa, 0.39
0.5%. Control values for UNaV and FENa were signifi-
cantly greater in the denervated than in the con-
tralateral nondenervated kidney. A substantial in-
crease was produced by the natriuretic fractions in
both UNaV (1.62 Eq/min; P < 0.0025) and FENa
(1.14%; P < 0.005), representing increments of 42%
and 45%, respectively. There were no significant dif-
ferences in GFR between the left and right kidneys
either during the control or the experimental clear-
ance period. No changes in UNaV or FENa occurred
in the noninfused normal contralateral kidneys. A
comparison of the effects of four fractions (CO, JO,
LU, DI) infused into normal kidneys (Table I) and
Table 2. Fractions from uremic patients administered intravenously to stage II rats with one intact and one remnant kidney: Effects on
glomerular filtration rate and sodium excretion
Fraction
Intact kidney Remnant kidney
GFR
mi/mm
UNaV
Eq/min
FENa
%
GFR
mi/mm
UNV
j.tEq/min
FEN,
%
RO Control
P0 Control
X
GU Control
CO Control
HO Control
Mean Control SEM
Mean + SEM
Pexp. vs. control
I
P intact vs. remnant
t
l.89
—0.42
2.18
—0.07
1.81
—0.07
1.99
—0.22
1.95
—0.07
1.96 0.06
—0.17 0.06
<0.05
2.98
+1.79
1.72
+2.86
2.58
+3.71
3.87
+2.48
3.44
+2.82
2.92 0.37
+2.73 0.31
<0.0005
1.16
+1.34
0.71
+0.98
1.17
+1.75
1.25
+1.13
1.50
+1.07
1.16 0.13
+ 1.25 + 0.14
<0.0005
NS
0.43
—0.09
1.03
—0.09
0.65
—0.03
0.65
—0.02
0.33
—0.01
0.62 0.12
—0.05 + 0.02
NS
<0.0005
1.76
+1.16
1.79
+0.97
0.91
+1.11
1.00
+0.50
1.16
+0.25
1.32 0.19
+0.80 0.18
<0.01
NS
3.12
+3.65
1.36
+1.13
1.16
+1.48
1.25
+0.77
2.52
+0.74
1.88 0.40
1.55 + 0.54
<0.025
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denervated kidneys (Table 3) reveals a significantly
greater increase in both UNaV (P < 0.025) and FENa
(P < 0.025) in the denervated organs.
Table 3 also compares the effects of the same seven
uremic fractions infused into stage III (remnant) kid-
neys with those observed in the denervated kidneys.
The mean control GFR was significantly lower in the
stage III kidneys (P < 0.0005); control values for
both UNaV and FENa were also significantly lower in
the remnant kidneys than in the denervated kidneys
(P < 0.005 and P <0.05, respectively). Despite these
differences UNaV increased in the remnant kidneys by
1.85 tEq/min, an increment which was not different
from that observed in denervated kidneys with ap-
proximately four times the number of nephrons;
FENa increased by 2.03% which was significantly
greater than that observed in the denervated kidneys
(P < 0.005). Expressed as percentage over control
values, UNa V increased by 168% and FENa by 150%
in remnant kidneys. Both these increments are
significantly greater than the percentage increments
of 42 and 45% observed in the denervated kidneys
(P < 0.0025).
Nonnairiuretic Fractions. The results of the studies
using nonnatriuretic fractions from normal subjects
are shown in Table 4. In none of the three experimen-
tal groups (stage I rats, stage I rats with left renal
denervation and stage III rats) was there a significant
change in UNaV, FENa or GFR. The lack of any
significant effects applied both to intragroup com-
parisons (infused vs. contralateral noninfused kid-
neys) in the stage I and stage I denervated groups,
and to intergroup comparisons. No significant
changes were observed in any of the groups in blood
pressure, hematocrit, CPAU, plasma Na or K concen-
trations and potassium excretion.
Discussion
The evidence that the natriuretic factor employed
in the present studies is linked to the patterns of
sodium excretion stems from several experimental
observations. I) The factor is detectable in the serum
and urine of uremic patients with high rates of frac-
tional sodium excretion, whereas it is not detectable
in comparable fractions obtained from normal sub-
jects with low values for FENa [5, 6]. 2) In dogs
rendered uremic by sequential reduction of renal
mass and fed a constant sodium intake, FENa rose as
GFR fell, and at high values for FENa, natriuretic
factor was detectable. In a second group of dogs
subjected to identical reduction of renal mass, so-
dium intake was decreased in exact proportion to the
fall in GFR. In these animals, FENa remained at
control levels (despite the presence of uremia), and
natriuretic activity was not detectable [7]. 3) In
patients with advanced uremia who have coexisting
nephrotic syndrome and are nonnatriuretic edema-
formers with low values for FENa,natriuretic activity
in serum and/or urine fractions was not detectable
[6]. 4) The factor recently has been demonstrated in
urine of normal dogs on a high salt intake and a
mineralocorticoid undergoing "escape" [8]. 5) Fi-
nally, the factor recently has been demonstrated in
Table 3. Fractions from uremic subjects infused into (a) the left renal artery of rats with left renal denervation and (b) the solitary renal
artery of stage Ill rats with remnant kidneys: Effects on glumerular filtration rate and sodium excretion
(a) Denervated kidneys (b) Remnant kidneys
GFR UNV FENa GFR UNaV FEN.
Fraction mi/win Eq/min % mi/mm /AEq/mmn %
CO Control 1.08 2.48 1.64 0.68 0.53 0.57
+0.08 +2.55 +1.39 —0.13 +1.26 +1.84
JO Control 1.23 8.12 5.52 0.51 0.91 1.36
—0.09 +0.97 +1.16 +0.16 +3.10 +2.72
LU Control 1.14 3.54 2.21 0.75 3.07 2.92
+0.13 +1.73 +0.92 +0.01 +3.42 +2.48
Dl Control 0.96 3.72 2.75 0.44 0.38 0.91
—0.01 +2.53 +2.02 +0.02 +1.61 +1.90
TB Control 1.08 2.07 1.20 0.35 0.93 1.81
X
—0.01 +0.75 +0.64 —0.01 +1.25 +2.37
AL Control 1.33 3.13 1.68 0.64 0.75 0.80
+0.01 +1.01 +0.76 +0.05 +1.00 +1.01
SM Control 0.98 3.69 2.59 0.53 0.80 1.08
.\ +0.06 +1.82 +1.06 —0.02 +1.30 +1.86
Mean control + SEM Ill 0.05 3.82 0.75 2.51 0.54 0.56 0.05 1.10 + 0.40 1.35 0.30
Mean SEM +0.02 0.03 + 1.62 0.28 + 1.14 + 0.18 +0.01 + 0.03 + 1.85 + 0.37 +2.03 + 0.21
P exp. vs. control NS
P denerv. vs. remnant I
<0.0025 <0.0005 NS <0.0025 <0.0005
NS
NS
t. <0.005
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normal young men undergoing "water immersion"
natriuresis [9].
In all of the foregoing states, the evidence suggests
that natriuretic factor appears to be produced in in-
creased amounts and/or that its biologic half-life is
prolonged. This evidence consists of the finding of a
greater activity of the natriuretic factor in the serum
and the simultaneous excretion of a greater quantity
of natriuretic factor in the urine than is found in
nonnatriuretic animals and man. A number of other
investigators have demonstrated the presence of na-
triuretic factor(s) or inhibitors of Na transport in the
blood or urine of normal animals and man [11—17].
The present studies were designed to examine the
possibility that the sensitivity of the nephron to the
biologic effects of the natriuretic factor increases as
the total nephron population and GFR diminish.
In normal hydropenic rats with a low baseline level
of FENa, infusion of the natriuretic factor into one
renal artery produced a small but statistically signifi-
cant increase in both UNflV and FENa in the infused
kidney only, with no changes occurring in the con-
tralateral organ. When the same quantity of the same
natriuretic fractions was infused into the renal artery
of the remnant kidney of stage III uremic rats, the
increase in both UNaV and FENa was significantly
greater than that observed in the stage I animals. The
fact that values for UNaV were greater in stage III
than stage I rats is especially significant in view of the
fact that the infused kidneys in the latter group had
Table 4. Fractions from normal subjects infused into the left renal artery of (a) normal (stage I) rats, (b) normal rats with left renal
denervation and a contralateral intact kidney and (c) uremic rats with a solitary remnant kidney: Effects on glomerular filtration
rate and sodium excretion
Fraction
C1
mi/mm
UNV
uEq/min
FEN
%
Right Left Right Left Right Left
a. Normal rats
GR Control 1.13 1.38 0.09 0.12 0.06 0.07
+0.31 —0.39 +0.05 —0.01 +0.01 +0.02
DR Control 1.60 1.60 2.51 2.80 1.10 1.23
+0.23 —0.03 +0.11 +0.14 —0.10 +0.09
KA Control 1.00 0.96 0.60 0.16 0.43 0.12
—0.10 +0.05 +0.04 0 +0.09 +0.01
FO Control 1.28 1.35 0.38 0.44 0.35 0.24
zX —0.45 +0.23 +0.04 +0.07 —0.12 +0.18
SK Control 1.53 1.61 1.09 0.95 0.49 0.40
+0.17 +0.11 +0.69 +0.75 +0.23 +0.23
Mean control SEM 1.31 0.09 1.39 + 0.12 0.93 0.43 0.90 + 0.50 0.48 + 0.17 0.41 0.21
Mean SEM +0.03 + 0.14 —0.01 0.10 +0.19 0.14 +0.19 + 0.14 +0.10 + 0.04 +0.11 0.15
Pexp. vs. control NS NS NS NS NS NS
GR Control
b. Left renal denervation
0.89 1.02 0.97 7.31 0.81 5.23
—0.04 —0.09 +0.38 —0.25 +0.34 +0.23
DR Control 1.35 1.51 0.46 3.38 0.24 1.59
X +0.17 —0.12 0.22 +1.21 +0.07 +0.67
KA Control 1.44 0.97 1.03 4.05 0.53 3.02
+0.23 —0.15 0.36 —0.94 +0.07 —0.37
FO Control 1.12 1.05 0.86 1.53 0.54 1.04
1.12 1.13 —0.10 —0.13 —0.05 —0.15
Mean control SEM 1.20 + 0.12 1.14 + 0.13 0.83 0.13 4.07 1.20 0.53 0.12 2.72 + 0.93
Mean SCM +0.09 + 0.06 —0.07 + 0.05 +0.22 + 0.11 —0.03 0.45 +0.11 0.08 +0.09 + 0.23
Pexp.vs.control NS NS NS NS NS NS
LU Control
c. Uremic (stage III) rats
0.76 2.73 2.29
Exp. L\ +0.15 —0.78 —0.58
MB Control 0.96 6.65 4.68
Exp. —0.01 +0.57 +0.54
ZA Control 0.86 1.04 0.82
Exp.z —0.07 +0.1 +0.20
FL Control 0.52 0.74 1.04
Exp. +0.10 +0.38 +0.26
JR Control 0.81 0.50 4.60
Exp. —0.08 —0.67 —0.23
Mean Control SEM 0.78 + 0.07 3.23 1.14 2.68 + 0.84
Mean SCM 0.02 0.05 —0.08 0.27 +0.04 0.20
Pexp. vs. control NS NS NS
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approximately four to five times as many nephrons as
in the former group.
The possibility was considered that this augmented
natriuresis could be due to the administration of the
same amount of the fraction to a smaller mass of
renal tissue with a diminished total blood flow lead-
ing to the delivery of higher concentrations to the
remaining nephrons. When, however, the same vol-
umes of the fractions were infused into the remnant
kidneys of stage II (nonazotemic) animals, the nat-
riuresis that ensued was significantly less than in stage
III remnant kidneys with comparable reductions in
renal mass and glomerular filtration rates. The possi-
bility that the increased responsivity of the remnant
kidney is due to some intrinsic change induced by the
reduction in renal mass per Se, rather than to an
adaptation associated with uremia, is also rendered
unlikely by the studies shown in Table 2. When nat-
riuretic factor was infused intravenously into stage II
rats, there was no significant difference between the
increments in FENa in the remnant vs. the con-
tralateral normal kidneys. The data thus indicate that
the enhanced natriuretic response is associated with
some aspect of the uremic state and not to any special
characteristics of the remnant kidney or a reduced
nephron population per Se.
A second possible explanation for the enhanced
responsiveness of the uremic rat to the natriuretic
factor is that the excretion of the factor is diminished
and that the biologic activity persists over a longer
period of time. We believe this to be unlikely both
because the concentration of the factor in the infusate
delivered directly into the renal artery of the remnant
kidneys presumably was orders of magnitude greater
than the concentration of any of the factor which
escaped either binding and/or inactivation or excre-
tion, and which recirculated in the systemic circula-
tion. It was to examine this possibility that com-
parison was made between the natriuretic response in
stage III vs. stage I rats during the first clearance
period after initiation of intrarenal infusion of the
factor. As indicated previously, the enhanced natriu-
retic response in the stage III animals was present
within the first 15 mm of observation.
Recent micropuncture studies [4, 18] have demon-
strated a depression of fractional sodium reabsorp-
tion in the proximal tubule and an increased delivery
of filtrate to more distal nephron sites in uremic
animals with remnant kidneys. Since this elevation in
delivery could presumably influence the responsive-
ness to the natriuretic factor, in that the factor has
been shown to act on distal nephrons sites [19], an
effort also was made to examine, as a separate vari-
able, the influence of baseline levels of FENa on the
natriuretic response using the model of acute renal
denervation which has been shown to decrease prox-
imal tubular sodium reabsorption without an effect
on GFR [20].
Infusion of the natriuretic factor into denervated
kidneys led to a natriuresis which was significantly
greater than in the nondenervated normal kidneys of
stage I rats, indicating that elevation of baseline so-
dium excretion enhances the response to the factor.
In order to determine whether the augmented re-
sponse of the remnant kidneys of stage III (uremic)
rats could be explained solely by increased control
values for sodium excretion, their response to the
natriuretic factor was compared with that of the de-
nervated kidneys. Control values for both absolute
and fractional sodium excretion were twice as high as
in the remnant kidneys yet the absolute increment in
sodium excretion was the same in the two groups
(despite the fact that the remnant kidneys had one-
quarter the number of nephrons). The relative magni-
tude of the change was, however, far greater in the
remnant kidneys (165%) than in the denervated kid-
neys (42%). The changes in fractional sodium excre-
tion (which relate tubular handling of sodium to the
filtered load of sodium) were significantly greater in
the remnant kidneys (150% increase) than in the de-
nervated kidneys (45% increase).
It may be argued that changes in FENa may not be
the most pertinent index of responsiveness and that
comparisons of absolute increments in sodium excre-
tion are more relevant. On the other hand, if control
values for FENa in denervated and remnant kidneys
are comparable, it is implicit that the ratio between
tubular rejection of sodium and filtered sodium must
be comparable. Since changes in the filtered load did
not occur in any of the present experiments, an in-
crement in FENa can only be due to an alteration in
tubular reabsorption. The greater increment, seen in
the uremic remnant kidneys as compared with the
denervated kidneys, can only be interpreted as in-
dicating an enhanced tubular responsiveness to the
natriuretic factor which is not specifically dependent
on the baseline conditions. This conclusion is further
supported by the finding that absolute sodium excre-
tion underwent a percentage increase over control
which was three times greater than in the denervated
kidneys.
These data indicate that the baseline rate of FENa,
and presumably distal sodium delivery, condition the
natriuretic response to the natriuretic factor. How-
ever, the enhanced responsivity of the residual neph-
rons in the stage III rats seems also to reflect a true
adaptive increase in end-organ sensitivity to the fac-
tor.
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